SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

AXGN

Axogen, Inc.
BEARISH
Impact 5/10
Horizonweeks Processed3d 10h ago SEC0000895421-26-000342
Passive stake amendment
Actionable Insight ▼ Bearish

Morgan Stanley's exit below the 5% threshold removes a large passive holder from the register. Monitor for further institutional selling pressure and whether other large holders follow suit. The reduction occurred during Q3 2026, prior to the strong Q3 earnings report on October 28, suggesting the exit was not driven by near-term fundamentals.

DirectionBearish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Morgan Stanley filed an amended Schedule 13G disclosing a 2.8% passive stake in Axogen as of September 30, 2026, down from its prior 5%+ position, and stating it has ceased to be a beneficial owner of more than 5% of the class. The reduction from above 5% to 2.8% represents a significant exit by a major institutional holder.

Key Financial Metrics

Stake
2.8%
Investor
Morgan Stanley

Key Facts

  • Morgan Stanley filed a Schedule 13G/A disclosing beneficial ownership of 1,662,486 shares of Axogen common stock as of September 30, 2026
  • The stake represents 2.8% of shares outstanding
  • Morgan Stanley stated it has ceased to be the beneficial owner of more than 5% of the class
  • The filing is an amendment to a prior 13G filing, indicating a reduction from a previously disclosed >5% position

Financial Impact

Morgan Stanley reduced its stake from above 5% to 2.8%, a reduction of at least 1.3 million shares (based on ~$3.5B market cap and ~$97M stake value at 2.8%)

ownership concentration

Risk Factors

  • Loss of a major institutional holder may signal reduced confidence or portfolio rebalancing away from Axogen
  • Potential for additional selling by other large holders if Morgan Stanley's exit is followed by other institutions

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000895421-26-000342
Document: 0000895421-26-000342-index.html0000895421-26-000342
Document: 0000895421-26-000342.txt0000895421-26-000342

Track record

19 reports on AXGN

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +32.04% at T+20 after the Oct 1, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Viewing Entry $55.78 Now $55.38 +0.72% settles Dec 15
  2. Nov 9, 20267d ago 8-K Bullish 5/10 Entry $50.64 Now $55.38 +9.36% settles Dec 8
  3. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $51.35 Now $55.38 +7.85% settles Dec 3
  4. Oct 28, 202619d ago 8-K Bullish 6/10 No price data
  5. Oct 28, 202619d ago Press Release Bullish 6/10 Entry $49.25 Now $55.38 +12.45% settles Nov 25
  6. Oct 2, 20266w ago SC 13G Neutral 4/10 Entry $37.22 to $49.37 Now $55.38 +48.79% ▲ +32.64% +35.11% vs SPY
  7. Oct 1, 20266w ago 8-K Bullish 6/10 Entry $37.39 to $49.37 Now $55.38 +48.11% ▲ +32.04% +33.85% vs SPY
  8. Oct 1, 20266w ago Press Release Bullish 6/10 Entry $37.39 to $49.37 Now $55.38 +48.11% ▲ +32.04% +33.85% vs SPY
  9. Sep 10, 20269w ago 424B5 Mixed 6/10 Entry $42.16 to $36.13 Now $55.38 +31.36% ▼ −14.30% −16.17% vs SPY
  10. Sep 10, 20269w ago 8-K Bullish 7/10 Entry $41.85 to $36.18 Now $55.38 +32.33% ▼ −13.55% −15.67% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens in 6h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026